|
FY2017
12 months to Dec 31, 2017
|
FY2016
12 months to Dec 31, 2016
|
FY2015
12 months to Dec 31, 2015
|
FY2014
12 months to Dec 31, 2014
|
FY2013
12 months to Dec 31, 2013
|
|
|---|---|---|---|---|---|
| Net income (loss) | |||||
| Operating activities | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation | |||||
| Stock-based compensation | |||||
| Acquired in-process research and development | |||||
| Loss on disposal of property and equipment | |||||
| Accretion of bond premium (discount) | |||||
| Net realized foreign currency translation loss | |||||
| Change in operating assets and liabilities: | |||||
| Receivables | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Accrued wages, benefits and other liabilities | |||||
| Deferred revenue | |||||
| Net cash used in operating activities | |||||
| Investing activities | |||||
| Purchases of property and equipment | |||||
| Proceeds from disposal of property and equipment | |||||
| Purchases of investments | |||||
| Purchase of acquired in-process research and development | |||||
| Proceeds from sale and maturities of investments | |||||
| Net cash provided by investing activities | |||||
| Financing activities | |||||
| Stock repurchase | |||||
| Proceeds from public offering | |||||
| Proceeds from exercise of warrant to purchase common stock | |||||
| Proceeds from the exercise of stock options | |||||
| Proceeds from stock purchases under employee stock purchase plan | |||||
| Net cash provided by financing activities | |||||
| Effect of exchange rate | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
Loading...